GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Meta Biomed Co Ltd (XKRX:059210) » Definitions » Debt-to-Revenue

Meta Biomed Co (XKRX:059210) Debt-to-Revenue : 0.72 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Meta Biomed Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Meta Biomed Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩34,760 Mil. Meta Biomed Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩30,081 Mil. Meta Biomed Co's annualized Revenue for the quarter that ended in Mar. 2024 was ₩90,010 Mil. Meta Biomed Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.72.


Meta Biomed Co Debt-to-Revenue Historical Data

The historical data trend for Meta Biomed Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meta Biomed Co Debt-to-Revenue Chart

Meta Biomed Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 1.11 0.59 0.64 0.54

Meta Biomed Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.60 0.55 0.52 0.72

Competitive Comparison of Meta Biomed Co's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, Meta Biomed Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meta Biomed Co's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Meta Biomed Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Meta Biomed Co's Debt-to-Revenue falls into.



Meta Biomed Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Meta Biomed Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(31945.849 + 12502.091) / 83100.722
=0.53

Meta Biomed Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(34759.688 + 30081.443) / 90010.18
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Meta Biomed Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Meta Biomed Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Meta Biomed Co (XKRX:059210) Business Description

Traded in Other Exchanges
N/A
Address
634 Yeonje-ri, Gangoe-myeon, Cheongwon-gun, Chungbuk, KOR, 363-951
Meta Biomed Co Ltd manufactures and markets suture and dental supplies. The company's dental products include endodontic materials, restorative materials, and bone graft material, as well as equipment, including Endo motor, and Endo System. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics and incontinence meshs; bone products consisting of bone substitutes and cement; and medical products, including endoscope and ultrasonic products.

Meta Biomed Co (XKRX:059210) Headlines

No Headlines